NCT04642547 2023-08-01
Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma
RenJi Hospital
Phase NA Completed
Clinical Trials
15 trialsNCT03170180 2022-06-15
Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer
Samsung Medical Center
Phase 2 Completed
NCT00100945 2016-12-13
Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00268346 2016-01-05
Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00258323 2015-09-30
Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00026299 2013-09-05
Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
University of Chicago
Phase 1/2 Completed
NCT00025350 2013-06-24
Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00025142 2013-05-15
Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00026364 2013-03-21
ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00071994 2013-02-27
Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
National Cancer Institute (NCI)
Phase 2 Completed
NCT00030524 2012-10-30
ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
NCT00215995 2012-01-13
Cisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric Carcinomas
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00137761 2009-11-02
Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00234416 2009-04-23
IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer
AstraZeneca
Phase 1/2 Completed
NCT00242788 2009-04-23
IRESSAâ„¢ In Combo With Xelodaâ„¢ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure
AstraZeneca
Phase 1/2 Completed